首页>
外国专利>
METHOD OF ISOLATING BIOLOGICALLY ACTIVE FRACTION CONTAINING CLINICALLY ACCEPTABLE NATIVE S-LIPOPOLYSACCHARIDES OBTAINED FROM BACTERIA PRODUCING ENDOTOXIC LIPOPOLYSACCHARIDES
METHOD OF ISOLATING BIOLOGICALLY ACTIVE FRACTION CONTAINING CLINICALLY ACCEPTABLE NATIVE S-LIPOPOLYSACCHARIDES OBTAINED FROM BACTERIA PRODUCING ENDOTOXIC LIPOPOLYSACCHARIDES
展开▼
机译:分离从细菌产生的内生性内毒素性脂多糖中含有的临床上可接受的天然S-脂多糖的生物活性成分的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A biologically active fraction comprising S-lipopolysaccharide (LPS) from Gram-negative bacteria, which produces endotoxin LPS as a main component, is disclosed. This fraction is selected from the group consisting of D-glucosamine and β-hydroxydecanoic acid, β-hydroxydodecanoic acid, β-hydroxytetradecanoic acid and β-hydroxyhexadecanoic acid in lipid A of S-LPS. The molar ratio of β-hydroxy acid is about 2: 1-4, and the molar ratio of D-glucosamine and higher fatty acids linked by amide and ester bonds in lipid A of S-LPS is about 2: 3-7. Also disclosed is a method of isolating BAF comprising predominantly Gram-negative S-LPS producing endotoxin S-LPS.;The obtained BAF has the pyrogenicity, low toxicity, and high immunogenicity of commercial polysaccharide vaccine levels, and can be used as a vaccine for mammals including humans. They may be considered as inducers of cytokines and as prophylactic resistant antishock agents.
展开▼